Home • News & Events News & Events Updates about Leica Biosystems. Transforming Conventional to Digital Pathology, Leica Biosystems Introduces Case Management Software to Support Aperio AT2 DX System for Primary DiagnosisPublished: 2 March 2020 VISTA, Calif.—Mar 2, 2020—Leica Biosystems, a globally recognized cancer diagnostics and workflow solution leader, today announced a significant development for anatomical pathology laboratories by bringing together its Aperio AT2 DX System—digital pathology whole slide imaging—with Aperio Path DX… Leica Biosystems and Sectra Partner to Pursue FDA Clearance for an Integrated Clinical Digital Pathology SolutionPublished: 2 December 2019 VISTA, CA –December 2nd, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, and the international medical imaging IT and cybersecurity company, Sectra, announce a collaboration to seek a combined 510(k) clearance from the U.S. Food & Drug Administration (FDA) in the… The Future of Pathology: Landmark initiative to spark conversation between pathology community and healthcare leadersPublished: 13 November 2019 International panel of pathologists drive forward-thinking agenda on role of pathology in transforming cancer diagnostics and improve patient care London, UK – Nov. 13, 2019. On International Pathology Day, Leica Biosystems, a world-leading cancer diagnostics company, today announced the launch of… Delivering Greater Throughput and Decreased Turnaround Time for Research Labs is the Focus of Leica Biosystems Next Generation Digital Pathology ScannerPublished: 9 August 2019 VISTA, CA – Aug 9, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack loading with priority… Leica Biosystems Receives FDA 510(k) Clearance to Market a Digital Pathology System for Primary DiagnosisPublished: 29 May 2019 VISTA, CA –May 29, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the U.S. A multi-center study supporting this… Leica Biosystems Receives US Patent for RTF Extreme Speed Scanning TechnologyPublished: 7 January 2019 VISTA, CA – January 7th, 2019 – Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has granted it a patent for RTF, its breakthrough “Real-Time Focusing” technology (US patent 9,841,590). This will enable high volume, extremely fast line… Pagination « Previous Page 1 Page 2 Page 3 Current page 4
